-
(-)-JQ1: Setting the Benchmark for Negative Controls in BET
2026-07-21
Explore the role of (-)-JQ1 as the gold-standard negative control in BET bromodomain research. This article clarifies its stereochemical and mechanistic nuances, delivering practical guidance for rigorous assay design and interpretation.
-
Docosahexaenoic Acid (DHA): Neuroprotection and Lipid Homeos
2026-07-21
Docosahexaenoic Acid (DHA) is an essential omega-3 fatty acid critical for neural and retinal membrane integrity and function. Experimental evidence demonstrates that DHA supplementation can reverse hippocampal lipid dysregulation and reduce cognitive dysfunction in postoperative models. Its anti-inflammatory and neuroprotective properties make DHA a focus of translational neuroscience research.
-
Partial BACE1 Inhibition Lowers Amyloid Beta Without Synapti
2026-07-20
Satir et al. (2020) reveal that partial inhibition of BACE1, a key enzyme in amyloid precursor protein processing, can reduce amyloid beta production by up to 50% without impairing synaptic transmission in neuronal cultures. These findings refine the therapeutic window for BACE inhibitor use in Alzheimer's disease research, suggesting moderate enzyme inhibition may avoid the synaptic side effects observed with higher exposures.
-
P2Y2 Receptors Drive Microglial Uptake of Aβ42 Peptide in Al
2026-07-20
This article examines how nucleotides released from Amyloid β-Peptide (1-42)-treated microglia enhance cell migration and Aβ42 uptake via P2Y2 receptor activation. The findings provide new mechanistic insight into microglial-mediated amyloid clearance, highlighting the P2Y2 pathway as a potential therapeutic target within Alzheimer’s disease research.
-
Dual-Emissive Ruthenium Probe Enables Ratiometric Imaging of
2026-07-19
This study presents a tris-heteroleptic ruthenium(II) complex capable of ratiometric, dual-emission detection and imaging of amyloid-β fibrils. The approach enhances sensitivity and reliability in monitoring Aβ aggregation, with implications for Alzheimer's research and probe development.
-
hiPSC-Derived Intestinal Organoids Advance Pharmacokinetics
2026-07-18
This study introduces a streamlined protocol to generate human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) exhibiting mature enterocyte-like function. The approach overcomes key limitations of traditional models, enabling more predictive in vitro pharmacokinetic studies for orally administered drugs.
-
Betaine Hydrochloride: Enhancing Metabolic Enzyme & Protease
2026-07-17
Betaine hydrochloride delivers robust reproducibility, high solubility, and data-driven performance for metabolic enzyme and protease assays. Leveraging insights from inflammation-cancer models, this article details applied workflows, protocol optimization, and troubleshooting strategies for advanced biochemical research.
-
Electrostatic Partitioning in α-Synuclein Condensates Reveal
2026-07-17
This study uncovers that α-synuclein condensates formed via liquid–liquid phase separation possess a highly negative electrostatic potential that governs the charge-dependent partitioning of proteins and small molecules. These findings refine our understanding of the physicochemical basis of molecular sorting within neurodegenerative disease-relevant condensates and emphasize the need for charge-aware probe design in protein labeling and imaging workflows.
-
KPT-330 (Selinexor), selective CRM1 inhibitor: Lab-Driven In
2026-07-16
This article unpacks validated laboratory scenarios where KPT-330 (Selinexor), selective CRM1 inhibitor (SKU B1464), delivers reliable, reproducible solutions for cell viability, apoptosis, and tumor inhibition assays. Using evidence-based Q&A, it guides researchers to optimize workflows, interpret data, and select trustworthy reagents for advanced cancer research.
-
Taltirelin Suppresses Acute and Chronic Itch in Mice Models
2026-07-16
This study demonstrates that Taltirelin, a long-acting TRH analog, significantly inhibits both acute and chronic itch behaviors in mouse models. The findings reveal new antipruritic properties of Taltirelin, broadening its utility as a research tool in neuroendocrine and sensory modulation fields.
-
Clasto-Lactacystin β-lactone: Redefining Proteasome Inhibiti
2026-07-15
This thought-leadership article explores the mechanistic, strategic, and translational dimensions of Clasto-Lactacystin β-lactone as a next-generation proteasome inhibitor. We connect the latest evidence on viral immune evasion, necroptosis control, and ubiquitin-proteasome pathway research to guide advanced translational workflows—escalating the discussion beyond traditional cancer and neurodegeneration paradigms.
-
CCCP Uncoupling: Advanced Insights for Mitochondrial Morphol
2026-07-15
Explore CCCP (carbonyl cyanide m-chlorophenyl hydrazine) as an advanced tool for dissecting mitochondrial morphology and function in live-cell models. This article uniquely connects uncoupler-driven mitochondrial dynamics to emerging biomarker strategies in neurodegenerative disease research.
-
Salvianolic acid B: Precision Antifibrotic Workflows for Fib
2026-07-14
Salvianolic acid B (Dan Shen Suan B) is redefining pulmonary fibrosis research with its targeted inhibition of lysyl hydroxylase 2, disrupting pathogenic collagen cross-linking at the molecular level. This guide translates new mechanistic findings into actionable, highly reproducible protocols for extracellular matrix remodeling, including troubleshooting insights for optimal performance.
-
Salvianolic Acid B: Applied Protocols for Pulmonary Fibrosis
2026-07-14
Salvianolic acid B (Dan Shen Suan B) is redefining fibrotic disease research by enabling selective, reproducible inhibition of collagen cross-linking in pulmonary fibrosis models. This guide translates recent mechanistic breakthroughs into stepwise workflows, troubleshooting strategies, and advanced applications for extracellular matrix remodeling studies. Discover how high-purity Salvianolic acid B from APExBIO empowers translational research with actionable, evidence-backed insights.
-
Docosahexaenoic Acid (DHA): Reliable Solutions for Cell Assa
2026-07-13
This article explores real-world challenges faced by researchers working with cell viability and neuroprotection assays, demonstrating how Docosahexaenoic Acid (DHA, SKU C4188) from APExBIO supports experimental reproducibility and sensitivity. Scenario-driven Q&A blocks highlight protocol optimization, data interpretation, and practical product selection, guiding scientists towards validated, literature-backed workflows.